FBLG ▲ +4.3% - FibroBiologics, Inc. $FBLG - FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial 27-AUG-2026 08:31 AM ET